Abstract

Research Article

Infection by SARS-CoV-2 in healthcare workers of a second level hospital

Guillermo Padrón-Arredondo*

Published: 06 May, 2022 | Volume 6 - Issue 1 | Pages: 012-016

Background: From the first COVID-19 case in Playa del Carmen, 370 cases of infection have been reported in our staff until December 31, 2020. 
Material and methods: Study in workers of the General Hospital who developed SAR-CoV-2 infection during the pandemic. A sample of 30 cases of both sexes with laboratory-confirmed infection was obtained. Descriptive statistics were used with measures of central tendency, dispersion and percentages. 
Results: In a sample of 30 workers there were 13 doctors, 6 nurses and 11 support workers. The age was obtained as a mean of 38.8 years and SD = 10.4. Only four risk factors were found. Of the 30 infected health workers, 27 were treated on an outpatient basis and three required hospitalization. 
Discussion: The main symptoms in health workers are alterations in the sensation of taste and smell, but unlike our study, was headache, fever and myalgia. Likewise, it has been observed that medical are the most affected, but in this study it was support and the least affected was nursing personnel. There is no doubt that asymptomatic carriers are a serious disease transmission problem such that transmission between health workers by asymptomatic carriers is possible as was observed in this analysis.

Read Full Article HTML DOI: 10.29328/journal.niogb.1001018 Cite this Article Read Full Article PDF

Keywords:

COVID-19; SARS-CoV-2; Healthcare workers; Nosocomial transmission; Asymptomatic carriers; Diagnostic testing

References

  1. Zheng C, Hafezi-Bakhtiari N, Cooper V, Davidson H, Habibi M, Riley P, Breathnach A. Characteristics and transmission dynamics of COVID-19 in healthcare workers at a London teaching hospital. J Hosp Infect. 2020 Oct;106(2):325-329. doi: 10.1016/j.jhin.2020.07.025. Epub 2020 Jul 28. PMID: 32730771; PMCID: PMC7384992.
  2. Barranco R, Ventura F. Covid-19 and infection in health-care workers: An emerging problem. Med Leg J. 2020 Jul;88(2):65-66. doi: 10.1177/0025817220923694. Epub 2020 May 22. PMID: 32441196.
  3. Rivett L, Sridhar S, Sparkes D, Routledge M, Jones NK, Forrest S, Young J, Pereira-Dias J, Hamilton WL, Ferris M, Torok ME, Meredith L; CITIID-NIHR COVID-19 BioResource Collaboration, Curran MD, Fuller S, Chaudhry A, Shaw A, Samworth RJ, Bradley JR, Dougan G, Smith KG, Lehner PJ, Matheson NJ, Wright G, Goodfellow IG, Baker S, Weekes MP. Screening of healthcare workers for SARS-CoV-2 highlights the role of asymptomatic carriage in COVID-19 transmission. Elife. 2020 May 11;9:e58728. doi: 10.7554/eLife.58728. PMID: 32392129; PMCID: PMC7314537.
  4. Lombardi A, Consonni D, Carugno M, Bozzi G, Mangioni D, Muscatello A, Castelli V, Palomba E, Cantù AP, Ceriotti F, Tiso B, Pesatori AC, Riboldi L, Bandera A, Lunghi G, Gori A. Characteristics of 1573 healthcare workers who underwent nasopharyngeal swab testing for SARS-CoV-2 in Milan, Lombardy, Italy. Clin Microbiol Infect. 2020 Oct;26(10):1413.e9-1413.e13. doi: 10.1016/j.cmi.2020.06.013. Epub 2020 Jun 20. PMID: 32569835; PMCID: PMC7305713.
  5. Gómez-Ochoa SA, Franco OH, Rojas LZ, Raguindin PF, Roa-Díaz ZM, Wyssmann BM, Guevara SLR, Echeverría LE, Glisic M, Muka T. COVID-19 in Health-Care Workers: A Living Systematic Review and Meta-Analysis of Prevalence, Risk Factors, Clinical Characteristics, and Outcomes. Am J Epidemiol. 2021 Jan 4;190(1):161-175. doi: 10.1093/aje/kwaa191. Erratum in: Am J Epidemiol. 2021 Jan 4;190(1):187. PMID: 32870978; PMCID: PMC7499478.                                                
  6. Woo Jeon Y, Suk Park E, Jae Jung S, Kim Y, Yong Choi J, Hang Kim H. Protection of Healthcare Workers Against COVID-19 at a Large Teaching Hospital in Seoul, Korea, Yonsei Med J. 2020; Jul; 61(7):631-4. https://doi.org/10.3349/ymj.2020.61.7.63
  7. Petrakis D, Margină D, Tsarouhas K, Tekos F, Stan M, Nikitovic D, Kouretas D, Spandidos DA, Tsatsakis A. Obesity ‑ a risk factor for increased COVID‑19 prevalence, severity and lethality (Review). Mol Med Rep. 2020 Jul;22(1):9-19. doi: 10.3892/mmr.2020.11127. Epub 2020 May 5. PMID: 32377709; PMCID: PMC7248467.
  8. Erener S. Diabetes, infection risk and COVID-19. Mol Metab. 2020 Sep;39:101044. doi: 10.1016/j.molmet.2020.101044. Epub 2020 Jun 23. PMID: 32585364; PMCID: PMC7308743.
  9. Bello-Chavolla OY, Bahena-López JP, Antonio-Villa NE, Vargas-Vázquez A, González-Díaz A, Márquez-Salinas A, Fermín-Martínez CA, Naveja JJ, Aguilar-Salinas CA. Predicting Mortality Due to SARS-CoV-2: A Mechanistic Score Relating Obesity and Diabetes to COVID-19 Outcomes in Mexico. J Clin Endocrinol Metab. 2020 Aug 1;105(8):dgaa346. doi: 10.1210/clinem/dgaa346. PMID: 32474598; PMCID: PMC7313944.
  10. Pugliese G, Vitale M, Resi V, Orsi E. Is diabetes mellitus a risk factor for COronaVIrus Disease 19 (COVID-19)? Acta Diabetol. 2020 Nov;57(11):1275-1285. doi: 10.1007/s00592-020-01586-6. Epub 2020 Aug 31. PMID: 32865671; PMCID: PMC7456750.
  11. Singh AK, Gupta R, Misra A. Comorbidities in COVID-19: Outcomes in hypertensive cohort and controversies with renin angiotensin system blockers. Diabetes Metab Syndr. 2020 Jul-Aug;14(4):283-287. doi: 10.1016/j.dsx.2020.03.016. Epub 2020 Apr 9. PMID: 32283499; PMCID: PMC7144598.
  12. Johnston SL. Asthma and COVID-19: Is asthma a risk factor for severe outcomes? Allergy. 2020 Jul;75(7):1543-1545. doi: 10.1111/all.14348. PMID: 32358994; PMCID: PMC7267381.             
  13. García-Moguel I, Díaz Campos R, Alonso Charterina S, Fernández Rodríguez C, Fernández Crespo J. COVID-19, severe asthma, and biologics. Ann Allergy Asthma Immunol. 2020 Sep;125(3):357-359.e1. doi: 10.1016/j.anai.2020.06.012. Epub 2020 Jun 14. PMID: 32553608; PMCID: PMC7293849.
  14. Lan FY, Filler R, Mathew S, Buley J, Iliaki E, Bruno-Murtha LA, Osgood R, Christophi CA, Fernandez-Montero A, Kales SN. COVID-19 symptoms predictive of healthcare workers' SARS-CoV-2 PCR results. PLoS One. 2020 Jun 26;15(6):e0235460. doi: 10.1371/journal.pone.0235460. PMID: 32589687; PMCID: PMC7319316.
  15. Clemency BM, Varughese R, Scheafer DK, Ludwig B, Welch JV, McCormack RF, Ma C, Nan N, Giambra T, Raab T. Symptom Criteria for COVID-19 Testing of Heath Care Workers. Acad Emerg Med. 2020 Jun;27(6):469-474. doi: 10.1111/acem.14009. Epub 2020 Jun 8. PMID: 32396670; PMCID: PMC7272901.
  16. Onoda M, Martínez Chamorro MJ. Pruebas diagnósticas de laboratorio de COVID-19. Grupo de Patología Infecciosa de la Asociación Española de Pediatría de Atención Primaria. Abril de 2020. Disponible en: [https://aepap.org/grupos/grupo-de-Patologiainfecciosa/contenido/documentos-delgpi]
  17. Castillo AF, Bazaes ND, Huete GÁ. Radiología en la Pandemia COVID-19: Uso actual, recomendaciones para la estructuración del informe radiológico y experiencia de nuestro departamento, Rev Chil Radiol. 2020; 26(3): 88-99.
  18. Chaccour C, Ruiz-Castillo P, Richardson MA, Moncunill G, Casellas A, Carmona-Torre F, Giráldez M, Mota JS, Yuste JR, Azanza JR, Fernández M, Reina G, Dobaño C, Brew J, Sadaba B, Hammann F, Rabinovich R. The SARS-CoV-2 Ivermectin Navarra-ISGlobal Trial (SAINT) to Evaluate the Potential of Ivermectin to Reduce COVID-19 Transmission in low risk, non-severe COVID-19 patients in the first 48 hours after symptoms onset: A structured summary of a study protocol for a randomized control pilot trial. Trials. 2020 Jun 8;21(1):498. doi: 10.1186/s13063-020-04421-z. PMID: 32513289; PMCID: PMC7276958.
  19. Lai CC, Liu YH, Wang CY, Wang YH, Hsueh SC, Yen MY, Ko WC, Hsueh PR. Asymptomatic carrier state, acute respiratory disease, and pneumonia due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): Facts and myths. J Microbiol Immunol Infect. 2020 Jun;53(3):404-412. doi: 10.1016/j.jmii.2020.02.012. Epub 2020 Mar 4. PMID: 32173241; PMCID: PMC7128959.
  20. Jones NK, Rivett L, Sparkes D, Forrest S, Sridhar S, Young J, Pereira-Dias J, Cormie C, Gill H, Reynolds N, Wantoch M, Routledge M, Warne B, Levy J, Córdova Jiménez WD, Samad FNB, McNicholas C, Ferris M, Gray J, Gill M; CITIID-NIHR COVID-19 BioResource Collaboration, Curran MD, Fuller S, Chaudhry A, Shaw A, Bradley JR, Hannon GJ, Goodfellow IG, Dougan G, Smith KG, Lehner PJ, Wright G, Matheson NJ, Baker S, Weekes MP. Effective control of SARS-CoV-2 transmission between healthcare workers during a period of diminished community prevalence of COVID-19. Elife. 2020 Jun 19;9:e59391. doi: 10.7554/eLife.59391. PMID: 32558644; PMCID: PMC7326489.

Figures:

Figure 1

Figure 1

Figure 1

Figure 2

Figure 1

Figure 3

Figure 1

Figure 4

Similar Articles

Recently Viewed

Read More

Most Viewed

Read More

Help ?